Weight-loss jab could be made for $3 a month, study finds
Cheap semaglutide, the drug in Ozempic and Wegovy, could help millions with diabetes and obesity in 160 countries Weight-loss jabs such as Wegovy could be made for just $3 a month, according to new analysis, potentially making the treatment available to millions in poorer countries as patents expire. More than a billion people live with obesity worldwide, with rates rising fast in lower-income nat
Source
The Guardian
Opens original article in a new tab